KMW Health Bureau
Srinagar, January 01: The Vaccine on Coronavirus Pandemic in India is likely to be reality soon. With reference to critical Covid Vaccine applications for the emergency use approval for the coronavirus vaccines filed by the Serum Institute of India, Bharat Biotech and Pfizer are being reviewed by a government-appointed panel of experts stated today.
As a matter of fact, this is second meeting in three days.
Pertinent to mention here that Serum Institute which is making the vaccine ‘Covishield’ developed by Oxford University and pharma major AstraZeneca and Bharat Biotech which has partnered the Indian Council of Medical Research (ICMR) for its ‘Covaxin’ had made presentations before the panel on Wednesday. Pfizer had sought more time to present their data.
As a matter of fact, once the vaccines are cleared by the expert panel, the applications will move to the Drugs Controller General of India (DCGI) for final approval. It is further learnt that the government wants to start administering the shots starting this month.
It is worth noting that Today’s meeting comes a day before a dry run for vaccinations in all states. Union Health Minister Harsh Vardhan, who will assess the mock drill in Delhi tomorrow, said, “The preparations are like general elections, where even the booth level preparations are made.”
On the other hand, the purpose of the dry run is to be ready for the actual rollout.
